Skip to search formSkip to main contentSkip to account menu

lipoplatin

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cisplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Nanotechnology in Cancer Treatment as a Trojan Horse: From the Bench to Preclinical Studies
  • G. Kordas
  • Nanostructured Polymer Composites for Biomedical…
  • 2019
  • Corpus ID: 196571384
Review
2015
Review
2015
Liposomes: A targeted drug delivery system- A review
Liposomes are a novel drug delivery system (NDDS), which are vesicular structures consisting of hydrated bilalyers which form… 
2014
2014
Preclinical Activity of the Liposomal Cisplatin Lipoplatin in Ovarian Cancer
Purpose: Cisplatin and its platinum derivatives are first-line chemotherapeutic agents in the treatment of ovarian cancer… 
2013
2013
Efficacy of cisplatin and Lipoplatin™ in combined treatment with radiation of a colorectal tumor in nude mouse.
BACKGROUND Optimal conditions for efficient concomitant chemoradiation treatment of colorectal cancer with cisplatin still need… 
2012
2012
Synergism in concomitant chemoradiotherapy of cisplatin and oxaliplatin and their liposomal formulation in the human colorectal cancer HCT116 model.
BACKGROUND We choose to test the effect of associating chemo-radiotherapy at 8 h (the highest level of DNA-platinum) and 48 h… 
2011
2011
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™)
PurposeCisplatin is one of the most effective cytotoxic agents in the treatment of solid malignancies, but its use is limited by… 
2009
2009
9088 Phase III study of Lipoplatin plus Gemcitabine versus Cisplatin plus Gemcitabine in advanced NSCLC; interim analysis
2008
2008
Liposomally-encapsulated cisplatin (Lipoplatin) plus gemcitabine in NSCLC: Preliminary results of a phase II trial and its antiangiogenesis potential
19024 Background: Liposomally-encapsulated cisplatin (Lipoplatin) nanoparticles evade immune surveillance, target tumor cells in… 
2007
2007
Lipoplatin plus gemcitabine versus cisplatin plus gemcitabine in NSCLC: Preliminary results of a phase III trial
18028 Background: Lipoplatin is a liposomal formulation of cisplatin, designed to reduce its adverse reactions without reducing… 
2005
2005
Systemic Lipoplatin infusion results in preferential tumor uptake in human studies.
Lipoplatin, a liposomal formulation of cisplatin, was developed with almost negligible nephrotoxicity, ototoxicity and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)